What does LabTurbo Biotech Corporation do?

LabTurbo Biotech Corporation (7725.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 7725.TWO's market cap?

LabTurbo Biotech Corporation (7725.TWO) has a market capitalization of approximately $1.08 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 7725.TWO pay a dividend?

Yes — LabTurbo Biotech Corporation (7725.TWO) pays a dividend annually, with a trailing-twelve-month yield of 0.89%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

Is 7725.TWO profitable?

LabTurbo Biotech Corporation (7725.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

7725.TWO

LabTurbo Biotech Corporation

TWO·Biotechnology · Healthcare

NT$22.50NT$0.50−2.17%

Market capNT$1.08B·Aug 26 3:53 AM UTC

Price Chart

NT$22.50−NT$0.50 (−2.17%)today

−43.61%CAGR −19.26%

Select date range

FromTo

Dec 22, 2023Dec 22, 2023 → Aug 26, 2026· 2.7 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.89%

Annual Dividend (FWD)NT$0.20

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent DividendNT$0.200

Ex-Dividend DateJul 8

Payment DateJul 31

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$94.29M

Net Income−NT$39.17M

Net Margin−41.5%

Operating Cash Flow−NT$91.73M

Capital ExpendituresNT$1.58M

Free Cash Flow−NT$93.31M

Return on Equity−3.4%

Return on Invested Capital−6.4%

Net CashNT$798.76M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 7725.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 7725.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 7725.TWO and 80,000+ other tickers.

About LabTurbo Biotech Corporation

Labturbo Biotech Corporation specializes in pioneering technological advancements. The company provides a range of sophisticated solutions for laboratory automation and molecular biology, which include their AIO SP-qPCR Automation System, Liquid Handling PCR Setup System, and DNA/RNA Extractor Compact Systems. Founded on June 12, 2019, its main operations are based in Taipei, Taiwan.

CEO: Chi Sheng Tai
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 30
Website: labturbo.com

Peers

Peers Tab

6810.TWO

Bio Preventive Medicine Corp.

Cap

NT$1.1B

6827.TWO

MegaPro Biomedical Co., Ltd

Cap

NT$821.1M

6814.TWO

Lukas Biomedical Inc.

Cap

NT$833.3M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 7725.TWO

What does LabTurbo Biotech Corporation do?: LabTurbo Biotech Corporation (7725.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 7725.TWO's market cap?: LabTurbo Biotech Corporation (7725.TWO) has a market capitalization of approximately $1.08 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 7725.TWO pay a dividend?: Yes — LabTurbo Biotech Corporation (7725.TWO) pays a dividend annually, with a trailing-twelve-month yield of 0.89%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.
Is 7725.TWO profitable?: LabTurbo Biotech Corporation (7725.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.